Fiscal Year:
2011
Title:
TAS::75 0893::TAS MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE
Agency:
HHS
Contract:
N44DA110019
Award Amount:
$745,047.00
Abstract:
The overall objective of this proposal is to develop a novel, simple, low-cost, on-site DOA test device and kit for measuring drugs of abuse for multiplex analysis capabilities based on the Contractor's patented ultra-sensitive Time-Resolved Luminescent Lateral Flow Assay Technology with digital reader. In order to make such a device available, the Contractor will research on multiplex lateral flow immunoassay (MLFIA) strip design and fabrication, as well as detection device development. The Contractor willalso establish a time-resolved MLFIA technology platform which includes new components on novel nanoparticles, and time-resolved detection.
Small Business Information at Submission:
BIOMEDOMICS, INC.
6 DAVIS DR DURHAM, NC 27709-2137
EIN/Tax ID:
999999999
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
Yes
HUBZone-Owned:
No